Search For "covid 19 drug"
Top drug regulator CDSCO suspends import license of Mumbai-based firm for
Updated : 5 years, 7 months ago IST
New Delhi [India], July 24 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has suspended the import license of Mumbai-based company--Transasia Bio-Medicals which is providing COVID-19 IgG ELISA kit.
Read More
Hyderabad police arrest 7 people for black marketing COVID-19 drugs
Updated : 5 years, 8 months ago IST
Hyderabad (Telangana) [India], July 18 (ANI): The Hyderabad Police arrested seven persons accused of illegally procuring and selling of COVID-19 antiviral drugs Covifor (Remdesivir) and Cipremi Injections, on Saturday.
Read More
Need for mandatory serial number, barcode and systems driven traceability
Updated : 5 years, 8 months ago IST
New Delhi [India], July 18 (ANI): A community engagement and social media platform has written to the Union Health Ministry suggesting that the government should make it mandatory for pharmaceutical manufacturers to implement serial numbers, bar codes and systems-driven end to end traceabili
Read More
Hyderabad: 8 held for illegally selling COVID-19 drugs
Updated : 5 years, 8 months ago IST
Hyderabad (Telangana) [India], July 15 (ANI): Hyderabad Police has claimed to have busted an interstate black marketing gang for allegedly selling emergency drugs for COVID-19, and seized Rs 55,000 cash along with drugs worth over Rs 35 lakh. Eight people have been arrested by the police so
Read More
Glenmark cuts COVID-19 drug Favipiravir price by 27 pc
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand name FabiFlu for treatment of patients with mild to moderate COVID-19 by 27 per cent to Rs 75 per tablet.
Read More
Union Health, HRD Minister inaugurate Drug Discovery Hackathon
Updated : 5 years, 8 months ago IST
New Delhi [India], July 2 (ANI): Union Health Minister Dr Harsh Vardhan along with Union Human Resource Development Minister Dr Ramesh Pokhriyal Nishank launched 'Drug Discovery Hackathon' through video conferencing here on Thursday.
Read More
Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' i
Updated : 5 years, 9 months ago IST
New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.
Read More
India to soon begin domestic production of Remdesivir drug to fight COVID-
Updated : 5 years, 9 months ago IST
New Delhi [India], June 13 (ANI): India is soon going to have its domestic production of anti-viral Remdesivir drug, which would have safety, efficacy and stability for "restricted emergency use" on COVID-19 patients.
Read More
Sun Pharma initiates phase two clinical trial on AQCH as potential treatme
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 5 (ANI): Sun Pharmaceutical Industries has started phase two clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19.
Read More
Combating COVID-19: AICTE, CSIR embark on drug discovery hackathon
Updated : 5 years, 9 months ago IST
New Delhi [India], May 28 (ANI): The All India Council for Technical Education (AICTE) and the Council of Scientific and Industrial Research (CSIR) have embarked on a drug discovery hackathon to fight against COVID-19, said Prof K Vijay Raghavan, Principal Scientific Advisor (PSA) to Gove
Read More
'Govt still not satisfied with the efficacy of antiviral drugs Remdesivir,
Updated : 5 years, 10 months ago IST
New Delhi [India], May 15 (ANI): The Union Health Ministry is still not satisfied with the efficacy of two antiviral drugs--Remdesivir and Favipiravir--for the treatment of COVID-19 patients.
Read More
Trump administration failed to scale up in time to distribute COVID-19 dru
Updated : 5 years, 10 months ago IST
Washington DC [USA], May 15 (Sputnik/ANI): There are not enough doses of the coronavirus trial drug remdesivir because the Trump administration failed to ramp up production and lacks a distribution plan, former government vaccine developer Rick Bright said on Thursday.
Read More